Introduction to Peptide-Based Metabolic Health Research Metabolic syndrome, obesity, insulin resistance, and type 2 diabetes represent some of the most pressing global health challenges of the 21st century. While pharmaceutical interventions have traditionally focused on single-target drugs, research peptides offer a multi-targeted approach to metabolic health, influencing appetite regulation, insulin sensitivity, fat metabolism, and energy […]
Tag Archives: Weight Loss
GLP-1 Receptor Agonists Complete Comparison: Semaglutide vs Tirzepatide vs Retatrutide vs Liraglutide 2026 GLP-1 receptor agonists have revolutionized metabolic research, becoming the most studied and searched class of peptides worldwide. From the original liraglutide to the latest triple agonists, each generation brings improved efficacy, broader receptor targeting, and new research possibilities. This comprehensive comparison covers […]
Tesofensine: The Triple Reuptake Inhibitor for Weight Loss Research Tesofensine is a novel monoamine reuptake inhibitor that targets serotonin, noradrenaline, and dopamine transporters simultaneously — a “triple reuptake inhibition” mechanism that produced some of the largest weight-loss effects observed in clinical trials. It reached phase 3 development for obesity before development paused, and it remains […]
Mazdutide (GLP-1/GCGR Dual Agonist): The Next-Generation Metabolic Peptide Guide Mazdutide is a once-weekly dual agonist of the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor (GCGR), developed for obesity and metabolic dysfunction. By combining GLP-1’s appetite suppression with glucagon’s energy expenditure effects, mazdutide represents a distinct mechanism among next-generation metabolic peptides. This guide reviews its […]
Cagrilintide: The Amylin Analog for Weight Management Research Cagrilintide is a long-acting analog of amylin, a pancreatic hormone that regulates appetite and satiety, developed for weight management and metabolic research. As the GLP-1 receptor agonist landscape expands, amylin analogs like cagrilintide represent a complementary mechanism — studied alone and in combination with semaglutide (cagrilintide 2.4mg […]
AOD9604 (HGH Fragment 177-191): The Fat-Burning Peptide Research Guide AOD9604 is a modified fragment of the human growth hormone (HGH) molecule, specifically the amino acid sequence 177-191, developed to replicate the lipolytic (fat-burning) effects of growth hormone without its growth-promoting or blood glucose effects. It has been studied extensively in obesity research and remains a […]
5-Amino-1MQ (NNMT Inhibitor): The Metabolic Research Compound Guide 5-Amino-1MQ is a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that has become a major focus of metabolic and longevity research. By suppressing NNMT activity, it raises NAD+ availability and drives metabolic pathways toward fat oxidation and energy expenditure. This guide covers its mechanism, research evidence, applications, dosing, and […]
MOTS-c: The Mitochondrial-Derived Metabolic Peptide Research Guide MOTS-c is a mitochondrial-derived peptide (MDP) encoded by the mitochondrial genome and involved in metabolic regulation, exercise adaptation, and cellular stress responses. Since its discovery, it has attracted intense research interest for its effects on insulin sensitivity, lipid metabolism, and age-related metabolic decline. This guide covers its mechanism, […]
Tesamorelin: Visceral Fat and Body Composition Research Guide Tesamorelin is a synthetic GHRH (growth hormone-releasing hormone) analog engineered with a longer half-life than earlier GHRH peptides. It is among the few GH-axis peptides that have been studied in large, controlled clinical trials — specifically for its ability to reduce visceral (abdominal) fat. This guide examines […]
Semaglutide vs Retatrutide: Complete 2026 Comparison Guide Semaglutide and retatrutide represent two generations of incretin-based research peptides that have transformed the field of metabolic research. While semaglutide is a single-target GLP-1 receptor agonist that set the modern standard, retatrutide is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This comprehensive guide compares […]
- 1
- 2